Zixiang, Wang – Trademark Portfolio
Entity Type: 01
Zixiang, Wang holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include SEARON and BRAPILOT. The owner is based in Ningbo, Zhejiang.
Rm. 1006, No. 33, Bldg. 10
Yunluwan S. Area, Cicheng Town, Jiangbei
Ningbo, Zhejiang 315000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zixiang, Wang's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Zixiang, Wang have?
Zixiang, Wang has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 abandoned.
What trademark classes does Zixiang, Wang file in?
Zixiang, Wang files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Zixiang, Wang's most well-known trademarks?
Zixiang, Wang's registered trademark portfolio includes well-known marks such as SEARON and BRAPILOT. These are among 4 currently registered trademarks in the portfolio.
What is Zixiang, Wang's trademark registration success rate?
Zixiang, Wang has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.